REQUEST DEMO
MENUCLOSE

 

REQUEST DEMO
Clinical Operations
Commercial Teams
Resources
Medical Education
About Us
Connect with us
Facebook-f Twitter Linkedin-in
Sign in

Category : News

CNS Web Post Image

ArcheMedX To Present New Findings & Clinical Trial Innovations At The CNS Summit

Analyses of 42,656 clinician learners across 69 CNS-related educational activities reveals clinicians may be unprepared to effectively conduct clinical trials Charlottesville, VA (PRWeb) November 16, 2022 ArcheMedX, the leading provider of clinician readiness solutions for the life sciences and healthcare industries, today announced the Company’s expanded participation at the CNS Summit taking
Continue Reading
3d illustration of a cancer cell and lymphocytes

ArcheMedX Releases New Oncology Findings Ahead Of ESMO Congress Revealing Clinician Readiness

2021 was a historic year in the battle to defeat cancer.   More novel cancer treatments became available than ever before with the number of Oncology specific clinical trials also reaching an all-time high, up 56% from 2016 and mostly focused on rare cancer indications. With global spending on Oncology expected to exceed $300
Continue Reading
big data

ArcheMedX Achieves Data Milestone Modeling Over 25 Million Learning Behaviors

ArcheMedX, a behavioral science-based learning company providing a smarter way to predict and improve clinical team performance, recently passed a significant data milestone. PRWeb - Charlottesville, VA March 24, 2022 Today, the Company announced its clinician learning and predictive analytics platform, Ready, has now surpassed more than 25 million essential learning behaviors
Continue Reading

AMA Recognizes ArcheMedX’s COVID-19 Report on Virtual Tech in Clinical Trials for Excellence

Today, ArcheMedX announced that its 2020 industry report, “COVID-19's Impact on Virtual Tech in Clinical Trials, was honored with a prestigious American Marketing Association (AMA) award. Every year, the AMA honors hundreds of stand-out marketers through awards programs presented by the AMA Foundation, local professional chapters, and academic special interest groups.
Continue Reading

ValenzaBio Selects Ready by ArcheMedX to Expedite Biomarker Study

CHARLOTTESVILLE, VA Apr. 21, 2021 -- ArcheMedX announced today that ValenzaBio, a biotech focused on developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, has selected Ready, the industry’s leading clinical trial learning and predictive analytics platform, to optimize performance on its upcoming Phase II study. ValenzaBio is deploying Ready to
Continue Reading

New Playbooks Authored by ArcheMedX Explore Digital Transformation in Clinical Trials

ArcheMedX, a leader in behavior-based learning and operational insights for life sciences organizations, announced the release of two new whitepaper companions to its recent report, “COVID-19's Impact on Virtual Tech in Clinical Trials.” These whitepapers, focused on clinical research organizations and clinical trial sponsors, respectively, are intended to be playbooks
Continue Reading
Social
Facebook-f Twitter Linkedin-in
Recent News
Contact Us

300 E Main Street, Suite 101 Charlottesville, VA 22902

+1-434-260-1850

Email Us

About Us

ArcheMedX helps life sciences and healthcare organizations to better equip, evaluate, and predict team and clinician performance

ArcheMedX Privacy Policy